Andrea Rachow
Overview
Explore the profile of Andrea Rachow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tientcheu L, Faal F, Top N, Jobe O, Colley S, Ayorinde A, et al.
Res Sq
. 2025 Mar;
PMID: 40060042
Tuberculosis (TB), caused by the complex (MTBC), remains a pressing global health challenge, with the West African region, including The Gambia, experiencing a substantial burden. This study explores the genetic...
2.
Sathar F, Charalambous S, Velen K, Fielding K, Rachow A, Ivanova O, et al.
BMJ Public Health
. 2025 Feb;
2(2):e001002.
PMID: 40018527
Introduction: In 2022, tuberculosis (TB) was the second-leading cause of global deaths from a single infectious agent. Delays in initiating TB treatment can lead to increased morbidity and mortality. We...
3.
Reimann M, Avsar K, DiNardo A, Goldmann T, Gunther G, Hoelscher M, et al.
Pathog Immun
. 2025 Feb;
10(1):120-139.
PMID: 39911144
Rationale: Treatment monitoring of tuberculosis patients is complicated by a slow growth rate of . Recently, host RNA signatures have been used to monitor the response to tuberculosis treatment. Objective:...
4.
Mapamba D, Sabi I, Lalashowi J, Sauli E, Buza J, Olomi W, et al.
J Infect
. 2025 Jan;
90(2):106379.
PMID: 39756697
Background: Half the global tuberculosis health burden is due to post-tuberculosis lung disease. Host-directed therapies have been proposed to reduce this burden. N-acetylcysteine (NAC) provides the conditionally essential amino acid...
5.
Ramachandran R, Dumitrescu A, Baiceanu D, Popa C, Dragomir A, Mahler B, et al.
J Health Popul Nutr
. 2024 Dec;
43(1):223.
PMID: 39710755
Background: Tuberculosis (TB) remains a global health challenge, with 1.3 million deaths in 2022. Ten countries in the European Union (EU) and European Economic Area (EEA) accounted for 88.3% of...
6.
Mangu C, Clowes P, van den Hombergh J, Mwakabenga C, Mwanyonga S, Ambindwile J, et al.
PLOS Glob Public Health
. 2024 Oct;
4(10):e0002372.
PMID: 39401196
There is an increased risk for tuberculosis (TB) infection and disease progression in prison settings. TB prevalence in prisons in low- and middle-income countries have been measured to be up...
7.
Wallis R, Sabi I, Lalashowi J, Bakuli A, Mapamba D, Olomi W, et al.
NEJM Evid
. 2024 Aug;
3(9):EVIDoa2300332.
PMID: 39189858
Background: Tuberculosis remains a global health concern, and half of cured patients have permanent lung injury. N-acetylcysteine (NAC) has shown beneficial antimicrobial, antioxidant, and immunomodulatory effects in preclinical tuberculosis models....
8.
Zielinski N, Baiceanu D, Dragomir A, Heyckendorf J, Ibraim E, Kohler N, et al.
Pathog Immun
. 2024 Jun;
9(2):25-42.
PMID: 38939039
Background: Neuropathic adverse events occur frequently in linezolid-containing regimens, some of which remain irreversible after drug discontinuation. Objective: We aimed to identify and validate a host RNA-based biomarker that can...
9.
Glover N, Ivanova O, Sathar F, Riess F, Shambhu R, Mekota A, et al.
EClinicalMedicine
. 2024 Apr;
71:102588.
PMID: 38623400
Background: Sequelae post-SARS-CoV-2 infection, including lung and functional impairment, pose a significant challenge post-recovery. We explored the burden and risk factors for post-COVID-19 sequelae in an African population with prevalent...
10.
Menzies N, Allwood B, Dean A, Dodd P, Houben R, James L, et al.
Nat Commun
. 2023 Oct;
14(1):6182.
PMID: 37794037
In 2020, almost half a million individuals developed rifampicin-resistant tuberculosis (RR-TB). We estimated the global burden of RR-TB over the lifetime of affected individuals. We synthesized data on incidence, case...